Non-surgical Recovery of a Chronic Subdural Hemorrhage Patient via the Exclusive Administration of <italic>Oryeong-san</italic>: A Case Report

Abstract

Introduction: Chronic subdural hemorrhage (CSDH) primarily affects the elderly, and its incidence is rising due to aging trends. Although burr-hole craniostomy is a common treatment for CSDH, it often has a high recurrence rate and can sometimes result in poor outcomes. Oryeong-san, a traditional Korean medicine, is emerging as a potential remedy, with documented cases in both Korea and Japan.Case Presentation: In March 2021, a patient was diagnosed with an intracerebral hemorrhage in the left basal ganglia. A subsequent brain computed tomography in June 2022 revealed CSDH. Given the potential need for surgery if no CSDH absorption occurred, the patient was treated with &lt;i&gt;Oryeong-san&lt;/i&gt;. Later computed tomography scans indicated that surgery was no longer necessary.Conclusions: This study evaluated the efficacy of &lt;i&gt;Oryeong-san&lt;/i&gt; in treating CSDH. The results demonstrated complete CSDH absorption with no observed side effects, highlighting &lt;i&gt;Oryeong-san&lt;/i&gt; as a promising and safe therapeutic option.